← Back to Search

Other

Low MAP Group for Traumatic Shock

N/A
Waitlist Available
Led By Matthew M Carrick, MD
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All adult patients seen in the Ben Taub emergency center that have suffered a trauma, have a systolic blood pressure less than 90mm Hg, and are going to the operating room for a laparotomy or thoracotomy
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

The goal of this study will be to determine if a lower than normal blood pressure during surgery for bleeding in the abdomen or chest will result in decreased bleeding and decreased chance of death.

Eligible Conditions
  • Trauma
  • Traumatic Shock
  • Hemorrhagic Shock
  • Multiple Trauma
  • Penetrating Wounds

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
30 day survival
Secondary outcome measures
APACHE II
ARDS
Acidosis (pH and BE)
+11 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Low MAP GroupExperimental Treatment1 Intervention
Hypotensive Group with a target minimum MAP of 50 mmHg
Group II: High MAP groupActive Control1 Intervention
Non experimental group: These patients will have a target minimum MAP of 65 mm Hg

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,001 Previous Clinical Trials
6,002,141 Total Patients Enrolled
Matthew M Carrick, MDPrincipal InvestigatorBaylor College of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~15 spots leftby May 2025